Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Steinman

Showing results (71-80 of 335) with videos related to

Pageof 34
Sort By:
Annals of Neurology|March 28, 2012
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis opticaLawrence Steinman, Scott S Zamvil
The Lancet. Neurology|July 12, 2011
Combining statins with interferon β in multiple sclerosis: think twice, it might not be all rightScott S Zamvil, Lawrence Steinman
Annals of Translational Medicine|February 7, 2017
Narcolepsy and influenza vaccination-induced autoimmunityS Sohail Ahmed, Lawrence Steinman
Nature Neuroscience|February 15, 2024
Hunger guides immunity to friend versus foeNoga Or-Geva, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitisPeggy P Ho, Lawrence Steinman
Current Opinion in Neurology|March 31, 2016
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosisLawrence Steinman, Scott S Zamvil
Science Translational Medicine|November 20, 2015
Response to comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2"Lawrence Steinman, S Sohail Ahmed
Science (New York, N.Y.)|January 13, 2022
Epstein-Barr virus and multiple sclerosisWilliam H Robinson, Lawrence Steinman
Nature Biotechnology|June 10, 2011
Human peptidome displayWilliam H Robinson, Lawrence Steinman
Trends in Immunology|September 13, 2005
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisLawrence Steinman, Scott S Zamvil
Pageof 34

Showing results (71-80 of 335) with videos related to

Sort By:
Pageof 34
Annals of Neurology|March 28, 2012
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis opticaLawrence Steinman, Scott S Zamvil
The Lancet. Neurology|July 12, 2011
Combining statins with interferon β in multiple sclerosis: think twice, it might not be all rightScott S Zamvil, Lawrence Steinman
Annals of Translational Medicine|February 7, 2017
Narcolepsy and influenza vaccination-induced autoimmunityS Sohail Ahmed, Lawrence Steinman
Nature Neuroscience|February 15, 2024
Hunger guides immunity to friend versus foeNoga Or-Geva, Lawrence Steinman
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitisPeggy P Ho, Lawrence Steinman
Current Opinion in Neurology|March 31, 2016
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosisLawrence Steinman, Scott S Zamvil
Science Translational Medicine|November 20, 2015
Response to comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2"Lawrence Steinman, S Sohail Ahmed
Science (New York, N.Y.)|January 13, 2022
Epstein-Barr virus and multiple sclerosisWilliam H Robinson, Lawrence Steinman
Nature Biotechnology|June 10, 2011
Human peptidome displayWilliam H Robinson, Lawrence Steinman
Trends in Immunology|September 13, 2005
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisLawrence Steinman, Scott S Zamvil
Pageof 34